InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Discover the full record of transactions filed by Murphy Polly A., Director. Director active across 1 companies, notably Atea Pharmaceuticals, Inc.. In total, 2 filings have been published. Total volume traded: €183k. The latest transaction was disclosed on 20 December 2021 — Acquisition. Regulator: SEC (Form 4). The full history is free.
Declarations2 total
€91,42612,000 shares@ €7.6189100.0% of flow
Common Stock
SEC:0000899243-21-049313·
Ideal exit: 16 Sept 2022 (T+270)
€91,42612,000 shares@ €7.61890.028% mcap50.0% of flow
Common Stock
SEC:0000899243-21-049313:0·
Ideal exit: 16 Sept 2022 (T+270)
2 of 2 declarations
About Murphy Polly A.
Polly A. Murphy is a Director at Atea Pharmaceuticals, Inc. She contributes to the governance of the company, bringing her expertise in the pharmaceutical field. Her experience allows her to actively participate in strategic discussions within the board.
